Intellia Therapeutics, Inc.
NASDAQ:NTLA
22.52 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -481.192 | -474.186 | -267.892 | -134.231 | -99.533 | -85.343 | -67.543 | -31.634 | -12.397 | -14.309 |
| Depreciation & Amortization
| 8.976 | 7.572 | 6.891 | 6.311 | 5.587 | 4.464 | 2.994 | 1.104 | 0.328 | 0.005 |
| Deferred Income Tax
| -10.192 | 0 | 8.929 | 0 | 0 | 0 | 0 | -6.702 | -1.012 | 0 |
| Stock Based Compensation
| 134.05 | 91.4 | 47.009 | 19.903 | 15.091 | 17.046 | 15.322 | 6.715 | 1.308 | 0.462 |
| Change In Working Capital
| -52.452 | -53.873 | -22.904 | 57.532 | -20.661 | 3.177 | -16.215 | 59.911 | 10.001 | 1.032 |
| Accounts Receivables
| -32.688 | -1.737 | 0.099 | 2.49 | 2.927 | 2.924 | -4.017 | -5.454 | -1.012 | 0 |
| Inventory
| -19.508 | 0 | 7.823 | 4.861 | 1.654 | 3.957 | 1.278 | -4.394 | 0 | 0 |
| Accounts Payables
| 2.522 | -4.584 | 0.529 | 5.06 | 1.88 | 0.232 | -0.488 | 1.784 | 0.335 | 0 |
| Other Working Capital
| -2.778 | -47.552 | -31.355 | 45.121 | -27.122 | -3.936 | -12.988 | 67.975 | 9.666 | 1.032 |
| Other Non Cash Items
| 6.724 | 95.8 | 2.937 | 0.573 | -3.724 | -0.601 | 0.166 | 6.715 | 0.009 | 9.327 |
| Operating Cash Flow
| -394.086 | -333.287 | -225.03 | -49.912 | -103.24 | -61.257 | -65.276 | 36.109 | -1.763 | -3.483 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -13.985 | -58.39 | -12.756 | -3.585 | -6.794 | -6.358 | -10.091 | -6.165 | -2.554 | -0.413 |
| Acquisitions Net
| 17.362 | -44.682 | -3 | 210.902 | -31.97 | 0.131 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -904.464 | -429.032 | -1,020.62 | -473.702 | -297.03 | -254.555 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 887.102 | 647.581 | 485.598 | 262.8 | 329 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -17.362 | 44.832 | -538.022 | -210.902 | 31.97 | 0.131 | -0.01 | 0 | 0 | -0.45 |
| Investing Cash Flow
| -31.347 | 160.309 | -550.778 | -214.487 | 25.176 | -260.782 | -10.091 | -6.165 | -2.554 | -0.863 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 119.795 | 565.789 | 736.688 | 358.648 | 72.256 | 28.971 | 141 | 167.904 | 74.059 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.1 | -2.671 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 10.528 | 17.166 | 736.688 | 13.131 | 4.178 | 11.246 | 1.981 | 167.304 | 72.959 | 19.113 |
| Financing Cash Flow
| 130.323 | 582.955 | 736.688 | 371.779 | 76.434 | 40.217 | 142.981 | 167.304 | 70.288 | 19.113 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -295.11 | 409.977 | -39.12 | 107.38 | -1.63 | -281.822 | 67.614 | 197.248 | 65.971 | 14.768 |
| Cash At End Of Period
| 240.353 | 535.463 | 125.486 | 164.606 | 57.226 | 58.856 | 340.678 | 273.064 | 75.816 | 14.768 |